Naproxen Extended Release Capsules

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.

The main ingredient of this product: naproxen. Chemical name ()-methyl-6-methoxy-2-naphthylacetic acid, molecular formula C14H14O3, molecular weight 230.26.

This product is a capsule, and the contents are off-white granules.

Suitable for relieving mild to moderate pain. Used to relieve rheumatism and rheumatoid arthritis, causing systemic fever, local swelling and pain.

Oral administration: Adults: 0.5g (2 tablets) once a day, or as directed by a doctor.

1. Itchy skin, shortness of breath, dyspnea, asthma, tinnitus, lower limb edema, stomach burning sensation, indigestion, stomach pain or discomfort, constipation, dizziness, drowsiness, headache, nausea and vomiting, etc.; 2. Blurred vision or visual impairment, hearing loss, diarrhea, oral irritation or pain, palpitations and sweating, etc.; 3. Gastrointestinal bleeding, kidney damage (allergic nephritis, kidney disease, renal papillary necrosis and renal failure, etc.), urticaria, allergic rash, depression, muscle weakness, bleeding or granulocytopenia and liver damage are less common.

This product should not be used by people with a history of allergy to this product or similar drugs, or those who have experienced asthma, rhinitis, and nasal polyposis syndrome caused by aspirin or other non-steroidal anti-inflammatory drugs. It is also contraindicated in patients with active gastric or duodenal ulcers.

Precautions for children: Children under 2 years old are prohibited. Precautions for pregnancy and lactation: Prohibited 1. The effects of this product on the fetus have not been fully studied, because other non-steroidal anti-inflammatory drugs can cause premature closure of the fetal ductus arteriosus, and because they can inhibit prostaglandin synthesis, leading to dystocia or prolonged labor. 2. The concentration of this product secreted into breast milk is equivalent to the percentage increase of blood drug concentration. It is not suitable for lactating women. Precautions for the elderly: The elderly should use it with caution.

1. When used with other non-steroidal anti-inflammatory drugs, gastrointestinal adverse reactions increase and there is a risk of ulcers; 2. When used with anticoagulants such as heparin and dicoumarol, bleeding time is prolonged, bleeding tendency may occur, and there is a possibility of gastrointestinal ulcers; 3. This product can reduce the sodium excretion and hypotensive effect of furosemide; 4. This product can inhibit the excretion of lithium in urine, so that the blood concentration of lithium increases; 5. When used with probenecid, the blood concentration of this product increases, T1/2 is prolonged, and the efficacy can be increased, but the toxicity reaction is also increased accordingly.

Keep away from light and store in sealed container.

0.25 g

Tentative 24 months

Jiangsu Nhwa Pharmaceutical Co., Ltd.

• Founded in:

  1999-03-29

• Address:

  No. 18, Yangshan Road, Xuzhou Economic and Technological Development Zone

• Tax NO.:

  913203001363846728

• Registered Funds:

  1016.176792 million yuan

• Website:

  Log in to view

• Email:

  Log in to view